Clinical Impact of Change of FLT3 Mutation Status in Acute Myeloid Leukemia (AML) Patients

被引：0
|
作者：
Warren, M.
Luthra, R.
Yin, C. C.
Ravandi, F.
Medeiros, L. J.
Zuo, Z.
机构：
[1] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1588
引用
收藏
页码：379A / 379A
页数：1
相关论文
共 50 条
  • [31] Midostaurin for Patients With Acute Myeloid Leukemia and FLT3 Mutations
    Levis, Mark James
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (06) : 323 - 325
  • [32] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [33] FLT3 inhibitors in acute myeloid leukemia
    Wu, Mei
    Li, Chuntuan
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [34] FLT3 Inhibitors in Acute Myeloid Leukemia
    Stone, Richard M.
    ONCOLOGIST, 2016, 21 : S2 - S2
  • [35] FLT3 inhibitors in acute myeloid leukemia
    Mei Wu
    Chuntuan Li
    Xiongpeng Zhu
    Journal of Hematology & Oncology, 11
  • [36] Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia
    Govedarovic, N.
    Marjanovic, G.
    JOURNAL OF BUON, 2011, 16 (01): : 108 - 111
  • [37] FLT3 inhibitors in acute myeloid leukemia
    不详
    ANNALS OF HEMATOLOGY, 2008, 87 : S87 - S89
  • [38] FLT3 Inhibitors for Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 573 - 575
  • [39] FLT3 inhibitors in acute myeloid leukemia
    Pastore, Domenico
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 14 - 21
  • [40] FLT3 inhibitors in acute myeloid leukemia
    el-Shami, Khaled
    Stone, Richard M.
    Smith, B. Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 153 - 160
12345